Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Attendees who have favorited this...
Cynthia De Luise
Pfizer Inc
Jennifer Gerber
Associate Director, Epidemiology
GSK
Katrina Hagberg
Boston Collaborative Drug Surveillance Program
Janet Hardy
Head of Pharmacoepidemiology
Biohaven Pharmaceuticals
Oystein Karlstad
Senior researcher
Norwegian Institute of Public Health
Georges Nahas
Merck & Co., Inc.
Elizabeth Newbern
Director
Johnson & Johnson
Daniel Prieto-Alhambra
Professor of Pharmaco- and Device Epidemiology
University of Oxford - EMC Rotterdam
Leyla Sahin
Acting Deputy Director for Safety, Division of Pediatrics and Maternal Health
US Food and Drug Administration
Lina Sy
Kaiser Permanente Southern California, Department of Research & Evaluation
